Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chao, C.-H.
Right arrow Articles by Wu Lee, Y.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chao, C.-H.
Right arrow Articles by Wu Lee, Y.-H.
[Cancer Research 66, 6579-6588, July 1, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

DDX3, a DEAD Box RNA Helicase with Tumor Growth–Suppressive Property and Transcriptional Regulation Activity of the p21waf1/cip1 Promoter, Is a Candidate Tumor Suppressor

Chi-Hong Chao1, Chun-Ming Chen2, Pei-Lin Cheng1, Jing-Wen Shih1, Ann-Ping Tsou3 and Yan-Hwa Wu Lee1

1 Institute of Biochemistry and Molecular Biology, 2 Faculty of Life Sciences, and 3 Institute of Biotechnology in Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China

Requests for reprints: Yan-Hwa Wu Lee, Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan 112, Republic of China. Phone: 886-2-2826-7124; Fax: 886-2-2826-4843; E-mail: yhwulee{at}ym.edu.tw.

DDX3 is a DEAD box RNA helicase with diverse biological functions. Using colony formation assay, our results revealed that DDX3 inhibited the colony formation ability of various tumor cells, and this inhibition might be due to a reduced growth rate caused by DDX3. Additionally, we identified p21waf1/cip1, a cyclin-dependent kinase inhibitor, as a target gene of DDX3, and the up-regulation of p21waf1/cip1 expression accounted for the colony-suppressing activity of DDX3. Moreover, DDX3 exerted its transactivation function on p21waf1/cip1 promoter through an ATPase-dependent but helicase-independent mechanism, and the four Sp1 sites located within the –123 to –63 region, relative to the transcription start site of p21waf1/cip1 promoter, were essential for the response to DDX3. Furthermore, DDX3 interacted and cooperated with Sp1 to up-regulate the promoter activity of p21waf1/cip1. To determine the relevance of DDX3 in clinical cancers, the expression profile of DDX3 in various tumors was also examined. A declined expression of DDX3 mRNA and protein was found in ~58% to 73% of hepatoma specimens, which led to the reduction of p21waf1/cip1 expression in a manner independent of p53 status. Additionally, an alteration of subcellular localization from nuclei to cytoplasm was also observed in >70% of cutaneous squamous cell carcinoma samples. Because DDX3 exhibits tumor suppressor functions, such as a growth-suppressive property and transcriptional activation of the p21waf1/cip1 promoter, and is inactivated through down-regulation of gene expression or alteration of subcellular localization in tumor cells, all these features together suggest that DDX3 might be a candidate tumor suppressor. (Cancer Res 2006; 66(13): 6579-88)




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
C.-S. Lee, A. P. Dias, M. Jedrychowski, A. H. Patel, J. L. Hsu, and R. Reed
Human DDX3 functions in translation and interacts with the translation initiation factor eIF3
Nucleic Acids Res., July 23, 2008; (2008) gkn454v2.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
B.-Y. Kang, S. Tsoi, Shan Zhu, Shenghui Su, and H. H. Kay
Differential Gene Expression Profiling in HELLP Syndrome Placentas
Reproductive Sciences, March 1, 2008; 15(3): 285 - 294.
[Abstract] [PDF]


Home page
Mol. Cell. Biol.Home page
A. M. Ambrus, B. N. Nicolay, V. I. Rasheva, R. J. Suckling, and M. V. Frolov
dE2F2-Independent Rescue of Proliferation in Cells Lacking an Activator dE2F1
Mol. Cell. Biol., December 15, 2007; 27(24): 8561 - 8570.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Ariumi, M. Kuroki, K.-i. Abe, H. Dansako, M. Ikeda, T. Wakita, and N. Kato
DDX3 DEAD-Box RNA Helicase Is Required for Hepatitis C Virus RNA Replication
J. Virol., December 15, 2007; 81(24): 13922 - 13926.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Yendamuri, F. Trapasso, M. Ferracin, R. Cesari, C. Sevignani, M. Shimizu, S. Rattan, T. Kuroki, K. R. Dumon, F. Bullrich, et al.
Tumor Suppressor Functions of ARLTS1 in Lung Cancers
Cancer Res., August 15, 2007; 67(16): 7738 - 7745.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
H. Qiu, B. Tian, R. G. Resuello, F. F. Natividad, A. Peppas, Y.-T. Shen, D. E. Vatner, S. F. Vatner, and C. Depre
Sex-specific regulation of gene expression in the aging monkey aorta
Physiol Genomics, April 24, 2007; 29(2): 169 - 180.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.